Bank of New York Mellon Corp - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 83 filers reported holding LEAP THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$12,064
-24.4%
35,4830.0%0.00%
Q4 2022$15,967
-48.5%
35,4830.0%0.00%
Q3 2022$31,000
-24.4%
35,4830.0%0.00%
Q2 2022$41,000
-36.9%
35,483
-4.0%
0.00%
Q1 2022$65,000
-45.8%
36,9740.0%0.00%
Q4 2021$120,000
-18.9%
36,9740.0%0.00%
Q3 2021$148,000
+142.6%
36,9740.0%0.00%
Q2 2021$61,000
-12.9%
36,9740.0%0.00%
Q1 2021$70,000
-23.9%
36,974
-9.3%
0.00%
Q4 2020$92,000
+27.8%
40,772
-34.2%
0.00%
Q3 2019$72,000
+71.4%
61,924
+165.8%
0.00%
Q2 2019$42,000
+100.0%
23,299
+119.0%
0.00%
Q4 2018$21,00010,6380.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders